Background: Spontaneous intracerebral hemorrhage (ICH) accounts for approximately 20% of all strokes and is associated with high mortality and disability rates. Despite numerous trials, conventional surgical approaches have not demonstrated consistent improvements in functional outcomes. Minimally invasive surgery (MIS) for ICH evacuation has emerged as a promising alternative, with the potential to improve functional outcomes and reduce mortality. Objectives: This narrative review aims to provide a comprehensive overview of various MIS techniques and their reported impact on functional outcomes in patients with spontaneous ICH while discussing key limitations in the existing literature. Methods: We systematically searched PubMed to identify studies published from 1 January 2010 to 22 March 2024. The search strategy included the following terms: (“minimally*”[All Fields] AND “invasive*”[All Fields] AND “surgery*”[All Fields] AND “intracerebral*”[All Fields] AND “hemorrhage*”[All Fields]) AND (2010:2024[pdat]). This review focuses on randomized controlled trials (RCTs) that evaluate MIS techniques for ICH and their clinical outcomes. Results: Our search identified six RCTs conducted between January 2010 and March 2024, encompassing 2180 patients with a mean age of 58.03 ± 4.5 years. Four trials demonstrated significantly improved functional recovery (mRs ≤ 3), reduced mortality, and fewer adverse events compared with standard medical management or conventional craniotomy. All MIS techniques rely on stereotactic planning and the use of tools such as exoscopes, endoscopes, craniopuncture, or thrombolytic irrigation for precise hematoma evacuation. These approaches reduce brain tissue disruption and improve precision. However, the variability in techniques, costs, and lack of an external validation limit the generalizability of these findings. Conclusions: MIS shows potential as an alternative to conventional management strategies for ICH, offering encouraging evidence for improved functional outcomes and reduced mortality in selected studies. However, these findings remain limited by gaps in the literature, including the need for external validation, significant methodological heterogeneity, and economic challenges. Further rigorous trials are essential to confirm the generalizability and long-term impact of these approaches.
Spinal metastases are the most common malignant involvement of the axial skeleton and a major source of cancer-related morbidity. Imaging is central throughout patient management, from initial detection and differential diagnosis of vertebral lesions to staging, treatment planning, and early identification of complications. Magnetic resonance imaging (MRI) is the reference modality owing to its high sensitivity for marrow infiltration and its ability to assess epidural extension and spinal cord compression in a single examination. Computed tomography (CT) remains essential for evaluating cortical destruction and mechanical instability, particularly within the Spinal Instability Neoplastic Score (SINS) framework, although it is less sensitive for early marrow disease. Nuclear medicine and positron emission tomography (PET) techniques provide complementary whole-body assessment, with performance depending on tumour biology. While bone scintigraphy has variable specificity, SPECT improves lesion localisation. 18F-FDG PET/CT sensitivity varies according to tumour phenotype, whereas 18F-NaF PET/CT demonstrates high sensitivity for osteoblastic metastases. In prostate cancer, PSMA PET/CT offers excellent staging accuracy. Complications, including pathological vertebral compression fractures and metastatic epidural spinal cord compression, are oncologic emergencies requiring prompt imaging. Current guidelines recommend urgent MRI, ideally within 24 h. Neural compromise is graded using the Bilsky ESCC scale, and instability is assessed with SINS. Emerging MRI-based morphometric parameters remain investigational. Differential diagnosis relies primarily on T1 marrow signal assessment, integrated with CT features and advanced MRI techniques. Optimal imaging strategies require integrating modality performance with tumour biology and clinical context to guide multidisciplinary decision-making.
Purpose: Spontaneous intracerebral hemorrhage (ICH) has a poor prognosis. Early imaging <72 hours is essential for etiological and prognosis assessment. We aimed to describe early imaging practices and evaluate their etiological relevance, before adopting standardized protocols. Methods: Acute spontaneous ICH patients from two university centers (2021–2022) were retrospectively included. Data included imaging, lesion, and associated vascular lesions parameters. Etiologies were classified into six categories based on imaging and clinical criteria: arteriolosclerosis, cerebral amyloid angiopathy (CAA), mixed cerebral small vessel disease (cSVD: arteriolosclerosis + CAA), vascular malformation, tumor, or undetermined. Results: Among 450 patients (71 ± 16 years; 52% male), initial imaging was CT in 58.5%; 53% had MRI <72 hours. 46% of baseline imaging comprised contrast-injection. CT-only patients were older, with larger hematomas and higher in-hospital mortality (all<0.05). ICH (48 ± 47 mL) was predominantly supratentorial (90%), with deep (52%) or lobar (frontal 28%) locations. MRI detected white matter hyperintensities (76%), lacunes (43%), infarcts (14%), acute ischemias (6%), and microbleeds (65%). CT identified an etiology in 50% vs. 80% for MRI ( p < .001), mainly mixed cSVD (34%), arteriolosclerosis (23%), CAA (14%), and vascular malformations (7%) when based on MRI. Follow-up imaging <72 h was done in 42%, mostly CT. Conclusions: Although CT was more frequent, MRI was superior for early etiological assessment of spontaneous ICH, mainly identifying cSVD-related causes. Broader use of early cerebral MRI could contribute to optimizing ICH care by improving identification of mixed cSVD patients and might help prevent secondary bleeding. Prospective and standardized MRI use in the early phase of ICH will clarify its role.